Please login to the form below

Not currently logged in
Email:
Password:

Future Thinking appoints Mohamed Muhsin as UK pharma head

Also names Véronique Bonrepaux-Caux head of healthcare France

Mohamed MuhsinFuture Thinking, a global company comprised of researchers, marketers, statisticians, strategists, innovators, creative and industry experts, has appointed Mohamed Muhsin (pictured left) as head of pharma UK.

Muhsin joins from QuintilesIMS Health, where he was therapy lead, oncology and prior to that he was a senior market analyst at Roche.

He said: “This is an exciting time for the pharmaceutical sector, as technology and innovation allows us to contemplate products that deliver tremendous value to healthcare stakeholders, which were unthinkable only a few year ago.

“I’m delighted to be joining Future Thinking and helping its clients navigate the opportunities and challenges that lie ahead for the sector.”Veronique Bonrepaux-caux

Additionally, the company has appointed Véronique Bonrepaux-Caux (pictured left) as head of healthcare France.

She joins from AlternativesPharma, where she was head of business development and her previous roles have seen her lead healthcare departments for Ipsos and Kantar TNS.

She said: “The healthcare space is always a challenging one, offering products and services to patients when they are at their most vulnerable.

“Working with Future Thinking is a great oppitunity to help healthcare organisations deliver the best service to their customers, as the expectations placed on them continue to grow.”

Both Muhsin and Bonrepaux-Caux will be focusing on expanding Future Thinking’s global footprint, technical capabilities and will be leveraging the company’s heritage in primary market research, behavioral economics and data science to build on client relationships.

27th July 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

For those who can imagine better, Page & Page is home to meaningful encounters of a marketing, communication and creative kind:...

Latest intelligence

Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
Generation Z
The roaring ‘20s and Generation Z
How a new generation will shape pharma comms this decade...

Infographics